Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mirage ileostomy bag Large outline cut 19mm-90mm clear
23605856107
|
Mirage ileostomy bag Large outline cut 19mm-90mm clear | Ileostomy Bags | Stoma Appliances | No data available |
|
Mirage ileostomy bag starter hole 19mm-44mm beige
23605856090
|
Mirage ileostomy bag starter hole 19mm-44mm beige | Ileostomy Bags | Stoma Appliances | No data available |
|
Mirage ileostomy bag starter hole 19mm-44mm clear
23605856100
|
Mirage ileostomy bag starter hole 19mm-44mm clear | Ileostomy Bags | Stoma Appliances | No data available |
|
Mirage ileostomy bag starter hole 19mm-64mm beige
23605856091
|
Mirage ileostomy bag starter hole 19mm-64mm beige | Ileostomy Bags | Stoma Appliances | No data available |
|
Mirage ileostomy bag starter hole 19mm-64mm clear
23605856101
|
Mirage ileostomy bag starter hole 19mm-64mm clear | Ileostomy Bags | Stoma Appliances | No data available |
|
Mirage urostomy bag
23965859675
|
Mirage urostomy bag | Urostomy Bags | Stoma Appliances | No data available |
|
Mircera 150micrograms/0.3ml inj pre-filled syringes
0901030N0BBADAD
|
Mircera | Methoxy polyethylene glycol-epoetin beta | Nutrition and Blood | No data available |
|
Mircera 200micrograms/0.3ml inj pre-filled syringes
0901030N0BBAEAE
|
Mircera | Methoxy polyethylene glycol-epoetin beta | Nutrition and Blood | No data available |
|
Mircera 250micrograms/0.3ml inj pre-filled syringes
0901030N0BBAFAF
|
Mircera | Methoxy polyethylene glycol-epoetin beta | Nutrition and Blood | No data available |
|
Mircera 360micrograms/0.6ml inj pre-filled syringes
0901030N0BBAIAI
|
Mircera | Methoxy polyethylene glycol-epoetin beta | Nutrition and Blood | No data available |
|
Mirtazapine 15mg orodispersible tablets sugar free
0403040X0AAAQAQ
|
Mirtazapine | Mirtazapine | Central Nervous System | No data available |
|
Mirtazapine 15mg/5ml oral solution
0403040X0AAASAS
|
Mirtazapine | Mirtazapine | Central Nervous System | No data available |
|
Mirtazapine 2mg capsules
0403040X0AAAIAI
|
Mirtazapine | Mirtazapine | Central Nervous System | No data available |
|
Mirtazapine 30mg/5ml oral liquid
0403040X0AAABAB
|
Mirtazapine | Mirtazapine | Central Nervous System | No data available |
|
Mirtazapine 45mg orodispersible tablets sugar free
0403040X0AAARAR
|
Mirtazapine | Mirtazapine | Central Nervous System | No data available |
|
Mirtazapine 4mg capsules
0403040X0AAAHAH
|
Mirtazapine | Mirtazapine | Central Nervous System | No data available |
|
Mirtazapine 750micrograms/5ml oral liquid
0403040X0AAAKAK
|
Mirtazapine | Mirtazapine | Central Nervous System | No data available |
|
Mirtazapine 75mg/5ml oral suspension
0403040X0AAAFAF
|
Mirtazapine | Mirtazapine | Central Nervous System | No data available |
|
Misabri PR 165mg pro-longed release tablets
0408010AEBGAABB
|
Misabri | Pregabalin | Central Nervous System | No data available |
|
Misabri PR 330mg pro-longed release tablets
0408010AEBGABBC
|
Misabri | Pregabalin | Central Nervous System | No data available |
|
Misabri PR 82.5mg pro-longed release tablets
0408010AEBGACBD
|
Misabri | Pregabalin | Central Nervous System | No data available |
|
Misofen 50mg/200microgram gastro-resistant tablets
1001010C0CNAAAM
|
Misofen | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Misofen 75mg/200microgram gastro-resistant tablets
1001010C0CNABAX
|
Misofen | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Misoprostol 400microgram tablets
0701010X0AAAAAA
|
Misoprostol (Gynaecology) | Misoprostol (Gynaecology) | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Misoprostol 7micrograms/hour vaginal delivery system
0701010X0AAABAB
|
Misoprostol (Gynaecology) | Misoprostol (Gynaecology) | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.